In Brief: Oxford Molecular Group/Alizyme
Executive Summary
Oxford Molecular Group/Alizyme: British companies agree to collaborate on research identifying agents for the treatment of obesity and related disorders, Oxford Molecular and Alizyme announce June 10. Collaboration will link Oxford Molecular's rational drug design, synthetic chemistry and biological screening abilities with Alizyme's discovery program to identify inhibitors of pancreatic lipase, which digests fatty foods...